Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.52 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.50 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.48 |
| ▸ | PPARG | P37231 | 7/20 | 0.48 |
| ▸ | PPARD | Q03181 | 7/20 | 0.48 |
| ▸ | PPARA | Q07869 | 7/20 | 0.48 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.48 |
| ▸ | TSHR | P16473 | 5/20 | 0.48 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.48 |
| ▸ | TLR2 | O60603 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | FABP4 | P15090 | 2/20 | 0.48 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.48 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | ESR1 | P03372 | 1/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | PDE4A | P27815 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17866310 | 0.98 | FFAR4 (0.55) | FFAR4FFAR1ALDH1A1AKR1B1GPR84 | |
| SCHEMBL11705517 | 0.98 | FFAR4 (0.55) | FFAR4FFAR1ALDH1A1AKR1B1GPR84 | |
| SCHEMBL1554385 | 0.93 | AKR1B1 (0.46) | FFAR4FFAR1ALDH1A1AKR1B1GPR84 | |
| Undecanol SCHEMBL29217481 | 0.86 | FFAR4 (0.57) | FFAR4FFAR1ALDH1A1AKR1B1GPR84 | |
| SCHEMBL6275213 | 0.85 | AKR1B1 (0.67) | FFAR4FFAR1ALDH1A1AKR1B1GPR84 | |
| SCHEMBL9361529 | 0.85 | FFAR4 (0.60) | FFAR4FFAR1ALDH1A1AKR1B1GPR84 | |
| SCHEMBL143442 | 0.84 | — | — | |
| SCHEMBL23829914 | 0.83 | FFAR4 (0.69) | FFAR4FFAR1ALDH1A1AKR1B1GPR84 | |
| SCHEMBL11513375 | 0.83 | FFAR4 (0.69) | FFAR4FFAR1ALDH1A1AKR1B1GPR84 | |
| SCHEMBL5915060 | 0.83 | FFAR4 (0.69) | FFAR4FFAR1ALDH1A1AKR1B1GPR84 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114214288-A | Zearalenone monoclonal antibody hybridoma cell strain and application thereof | 江南大学 | 2022-03-22 | — | — | CN | claimed |
| CN-113214109-A | Nifurosol hapten, artificial antigen, preparation methods and applications thereof | 中国农业大学 | 2021-08-06 | — | — | CN | claimed |
| US-20260069539-A1 | LIPIDOID COMPOUNDS AND RELATED COMPOSITIONS AND USES | POSEIDA THERAPEUTICS INC (US) | 2026-03-12 | — | — | US | disclosed |
| US-20260008793-A1 | IONIZABLE CATIONIC LIPIDS INCORPORATING SILICON | ALDEXCHEM KFT (HU) | 2026-01-08 | — | — | US | disclosed |
| EP-4652153-A1 | LIPIDOID COMPOUNDS AND RELATED COMPOSITIONS AND USES | Poseida Therapeutics, Inc. (US) | 2025-11-26 | — | — | EP | disclosed |
| EP-4562021-A2 | IONIZABLE CATIONIC LIPIDS INCORPORATING SILICON | AldexChem Kft. (HU) | 2025-06-04 | — | — | EP | disclosed |
| CN-119630681-A | Silicon-containing ionizable cationic lipids | 阿尔迪斯化学有限责任公司 | 2025-03-14 | — | — | CN | disclosed |
| US-20250059131-A1 | FLUORINATED CATIONIC LIPIDS FOR USE IN LIPID NANOPARTICLES | ACUITAS THERAPEUTICS INC (CA) | 2025-02-20 | — | — | US | disclosed |
| EP-4448482-A2 | FLUORINATED CATIONIC LIPIDS FOR USE IN LIPID NANOPARTICLES | Acuitas Therapeutics, Inc. (CA) | 2024-10-23 | — | — | EP | disclosed |
| CN-118647599-A | Fluoro cationic lipids for lipid nanoparticles | 爱康泰生治疗公司 | 2024-09-13 | — | — | CN | disclosed |
| WO-2024155938-A1 | LIPIDOID COMPOUNDS AND RELATED COMPOSITIONS AND USES | POSEIDA THERAPEUTICS, INC. (US) | 2024-07-25 | — | — | WO | disclosed |
| WO-2023114937-A2 | FLUORINATED CATIONIC LIPIDS FOR USE IN LIPID NANOPARTICLES | Acuitas Therapeutics, Inc. (CA) | 2023-06-22 | — | — | WO | disclosed |
| CN-115850618-A | Dynamic cross-linked azobenzene liquid crystal elastomer with linear/star SBS block copolymer as main chain and preparation method thereof | 大连理工大学 | 2023-03-28 | — | — | CN | disclosed |
| CN-115322969-A | Anti-trichlorfon monoclonal antibody, monoclonal cell strain and application | 江南大学 | 2022-11-11 | — | — | CN | disclosed |
| CN-115261647-A | Morpholine carboxylic acid ionic liquid and method for extracting and separating samarium by using same | 成都理工大学 | 2022-11-01 | — | — | CN | disclosed |
| CN-113214109-B | Nifurosol hapten, artificial antigen, preparation methods and applications thereof | 中国农业大学 | 2022-09-23 | — | — | CN | disclosed |
| CN-114214288-A | Zearalenone monoclonal antibody hybridoma cell strain and application thereof | 江南大学 | 2022-03-22 | — | — | CN | disclosed |
| US-20210289794-A1 | COMPOSITIONS AND RELATED METHODS FOR AGRICULTURE | FLAGSHIP PIONEERING INNOVATIONS V, INC. | 2021-09-23 | — | — | US | disclosed |
| CN-113214109-A | Nifurosol hapten, artificial antigen, preparation methods and applications thereof | 中国农业大学 | 2021-08-06 | — | — | CN | disclosed |
| US-20080214542-A1 | Arylpiperazine Derivatives and their Use as Selective Dopamine D3 Receptor Ligands | BIOPROJET (FR) | 2008-09-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250059131-A1 | FLUORINATED CATIONIC LIPIDS FOR USE IN LIPID NANOPARTICLES | PHOSPHO1, NPC1, SGMS1 | FFAR4 215/4885FFAR1 82/4885ALDH1A1 2594/4885 |
| US-20260069539-A1 | LIPIDOID COMPOUNDS AND RELATED COMPOSITIONS AND USES | STARD3, LPCAT3, LPCAT1 | FFAR4 847/4885FFAR1 549/4885ALDH1A1 1692/4885 |
| US-20080214542-A1 | Arylpiperazine Derivatives and their Use as Selective Dopamine D3 Receptor Ligands | SLC6A3, ADRB3, PRLHR | FFAR4 347/4885FFAR1 281/4885ALDH1A1 665/4885 |
| US-20260008793-A1 | IONIZABLE CATIONIC LIPIDS INCORPORATING SILICON | SGMS1, SGMS2, AGO2 | FFAR4 1898/4885FFAR1 422/4885ALDH1A1 2980/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.